Loading viewer...
investor_presentation
Format: PDF investor_presentation
NCBA Group's FY 2023 investor briefing highlights strong financial performance with PAT of KES 21.5B (+56% YoY) and ROAE of 24.1%. The presentation covers the Group's market leadership positions, improved subsidiary contributions, and accelerating digital disbursements of KES 930B (+27% YoY), while maintaining disciplined credit risk management with a 12% NPL ratio.
Xperi TiVo Merger: Consumer Entertainment Technology IP Licensing
investor_presentationinvestor_presentation
20 Pages
Xperi Corporation and TiVo Corporation
BriaCell Therapeutics Investor Presentation December 2023
investor_presentationinvestor_presentation
21 Pages
BriaCell Therapeutics Corp.
Teva Pharmaceutical Industries Investor Presentation — February 2021
investor_presentationinvestor_presentation
44 Pages
Teva Pharmaceutical Industries